Thrivent Financial for Lutherans
INDV icon

Thrivent Financial for Lutherans’s Indivior Pharmaceuticals INDV Stock Holding History

Thrivent Financial for Lutherans’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Sell
80,062
-3,276
-4% -$119K 0.01% 1203
2026
Q1 		$2.54M Buy
+83,338
New +$2.75M ﹤0.01% 1275

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thrivent Financial for Lutherans's INDV Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its Indivior Pharmaceuticals (INDV) stake by 3.9% in Q2 2026, selling an estimated $119K and leaving 80,062 shares worth $3.29M. The position accounts for 0.01% of the portfolio, ranked #1203.

Thrivent Financial for Lutherans first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Thrivent Financial for Lutherans held 80,062 shares of Indivior Pharmaceuticals worth $3.29M as of Q2 2026.
  • Thrivent Financial for Lutherans sold 3,276 Indivior Pharmaceuticals shares in Q2 2026, an estimated $119K.
  • Indivior Pharmaceuticals made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1203 holding.
  • Thrivent Financial for Lutherans first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.